Fitness enthusiasts use glucose displays, raising health care issues

Paloma Kemak, a local Arizonan, makes use of social media to place a highlight on steady glucose displays, tiny medical units which have revolutionized diabetic health care.

She fills her Instagram feed with the floral backdrops, journey pictures, wide-brimmed hats and pet portraits which have grow to be the mainstay of the trendy influencer. And every now and then, she posts pictures during which she poses with the again of her arm dealing with the digital camera to indicate off a much less frequent accent — the small white sensor that displays her blood glucose ranges.

Kemak, who has Type 1 diabetes (her deal with is @glitterglucose), says she created her on-line presence to fill a spot she noticed in the actual world: optimistic illustration of diabetics like her.

“I just like to show my life and how great and fun and cool it is,” she mentioned.

She says she has usually felt misunderstood and annoyed by non-diabetics who don’t perceive why she had a chunk of technology connected to her arm. When Kemak occurs to see another person sporting a CGM out in public, she says that’s usually an indication that she’s “going to make a new friend.”

In 2019, Kemak noticed a stranger at Starbucks sporting the identical CGM as she was, and approached him to strike up a dialog. Instead of the standard diabetes-related bonding, although, he gave her an sudden response.

“He was like, ‘Oh, I don’t have diabetes…you should just eat better,’” Kemak mentioned. “I was so shocked.”

For many diabetics, CGMs are an important device, mechanical units that repeatedly measure the degrees of sugar in an individual’s blood. A small patch affixes to the pores and skin on areas such because the arm or abdomen, and the CGM transmits its readings to a sensor or telephone, the place the consumer can learn real-time measurements.

But diabetics aren’t the one ones who can use CGMs.

Though Kemak’s expertise may need been an anomaly for her, increasingly more non-diabetics are beginning to use CGMs. And like Kemak, they put up about it.

They movie themselves attaching the sensor to their biceps, triceps or abdomen. In some posts, a CGM seems tiny alongside cross-country skis, big barbells, outside vistas and plates of perfectly-portioned meals. Recipes abound, as do exercise regimens. 

Charismatic and infrequently clad in matching exercise gear, CGM influencers promise what so many different wellness and health accounts on social media promote: higher health, higher sleep, a extra “optimized” physique. They peddle a spread of diets, from carnivore to vegan, with various quantities of scientific proof to again up their claims.

The broad vary of accessible proof hasn’t stopped startups, and buyers, from advertising and marketing the technology anyway. Levels, a “metabolic health” company that connects sufferers with physicians who can write prescriptions for CGMs and sells proprietary information monitoring software to customers, acquired $12 million in seed funding within the fall of 2020.

Other CGM startups abound: Online health information web site Healthline estimates that no less than 39 firms are devoting consideration to the technology in a single kind or one other. And rumors abound that common wearables just like the Apple Watch or Fitbit could embrace glucose monitoring in forthcoming fashions.

But some firms sponsoring glucose monitoring influencers would not have management over the content material related to their manufacturers if it’s not on their platform. That implies that, although they will monitor social media for claims being made about CGMs, it’s not essentially inside their purview to stop the unfold of misinformation or untested health claims.

“We don’t prescribe (any) specific diets,” mentioned Dan Zavorotny, chief working officer of NutriSense, a health and wellness company that helps shoppers to get a CGM prescription. They do this by connecting them to a community of medical doctors of their state who can write a prescription for the technology. NutriSense additionally gives subscribers with health information software and entry to a licensed dietitian by their app. 

“We’ve had folks who follow the ketogenic diet, we’ve had folks who follow the vegan diet, and our ambition isn’t to tell them like ‘hey, switch from ketogenic to vegan’ or vice versa. It’s about improving what they are currently doing,” Zavorotny mentioned.

Heather Walker, affiliate director of qualitative analysis on the University of Utah Health who has studied social components of diabetes, thinks these sorts of life enhancements don’t fall underneath the purview of CGMs, which had been designed with diabetics in thoughts. “You’re making a game out of a life circumstance that’s actually really challenging,” she mentioned of firms that market CGMs to non-diabetics.

But the road between gamification and medical necessity continues to be not firmly established, particularly because the scientific group waits for formal research on CGM outcomes for different circumstances.

Kevin Jubbal, a doctor, entrepreneur and public-facing CGM consumer related to startup company Levels, described how he determined to use a CGM to assist handle his Crohn’s illness. 

When he was a freshman in faculty, Jubbal had his first “flare.” People with Crohn’s illness, a sort of inflammatory bowel illness (IBD), typically expertise critical GI signs equivalent to diarrhea, and even different issues like fever and joint irritation. Jubbal says when he had that first flare, he was hospitalized for 4 days and lost over 30 kilos.

“It was a scary time, and that’s when I started really prioritizing health,” he mentioned. “It puts into perspective that nothing else matters.”

After experimenting along with his weight-reduction plan for years, he began to determine what made his signs higher and worse. Keto made issues worse. He tried a plant-based weight-reduction plan, and seen that lowering dairy helped along with his signs. He tried minimizing nuts and averted sweets. 

In 2019, he tried his first CGM. He watched his blood sugar spiking “all the time,” and was capable of see how these spikes coincided with different components in addition to weight-reduction plan, together with sleep, stress, train and extra.

“I remember thinking that I have a lot of room for improvement,” he mentioned.

He didn’t put on a CGM always after that, however now he’s been sporting one for the previous a number of months. He says it helps him keep on monitor with the very best practices that assist him keep away from flares.

“I think the main lessons are very similar to the main lessons I learned from the first two or three months. But what I see now is, I’m getting more continuous feedback that holds me accountable,” Jubbal mentioned. “I have noticed for sure that when I wear the CGM, I eat better than when I don’t because I hate seeing that spike.”

Jubbal thinks that scientifically talking, CGMs might be helpful for managing different circumstances past diabetes, an thought he’s examined out firsthand. 

“Me having these processed sugars is worsening my inflammation, and that inflammation is tied to my IBD … I think it’s based on what we know of the human body and how it works, (and) it totally makes sense,” he mentioned. “But we need more evidence to support it … to prove it through studies, to then make the decisions to cause the insurance companies to change their decisions about what they want to cover.”

As the technology improves, he thinks it would grow to be extra common. But for now he’s doing what many diabetics do out of necessity for a situation that he may in all probability handle and not using a CGM.

That’s not one thing everybody will essentially respect or condone. “You have to be a certain kind of weird to enjoy doing this kind of stuff,” Jubbal mentioned. “Because it does take more work.”

David Grigsby holds up the reader for his steady glucose monitor (CGM) outdoors a Tucson health clinic the place he’s a affected person on Feb. 17, 2022.
Melina Walling/The Republic

It’s a selection that doesn’t essentially make sense to David Grigsby, a affected person on the El Rio health clinic in Tucson who, earlier than his expertise along with his practitioner Lisa Beckett, didn’t suppose CGMs would ever be for him.

“If I didn’t have diabetes, I’d be like, ‘Well, would I want to have this thing stuck on me and having to do this stuff? I wouldn’t,’” he mentioned.

“If it wasn’t for the insurance companies, I wouldn’t be able to afford it,” Grigsby mentioned. “Why would people want to spend that kind of money, and they really don’t need it? I would think that’s just a waste.”

Grassroots networks and the way forward for CGMs

Brandon Lopez says when he was youthful, utilizing a CGM was a dream.

Now he is working a grassroots effort to assist others fulfill that dream, one which large CGM firms say is aligned with their mission, however that some sufferers say nonetheless is not reaching them.

Brandon Lopez, founder of The Embrace Foundation, finds insulin to send to people with diabetes inside a storage company in Chandler where the company operates.
Brandon Lopez, founding father of The Embrace Foundation, finds insulin to ship to folks with diabetes inside a storage company in Chandler the place the company operates.
Patrick Breen/The Republic

Lopez was recognized with diabetes at age 7. While he was dwelling along with his mother and father, he had an insulin pump — till he went on a hike, the pump broke, and he needed to change to a number of each day insulin injections.

“I thought (a CGM) was something I’d never be able to afford,” Lopez mentioned. “Something that only rich people can afford. That was a fantasy for me.”

In 2019, he acquired a job that had higher health insurance coverage and that dream of with the ability to use a CGM turned a actuality.

“It’s life-changing,” he mentioned.

But he didn’t cease there. In 2017, he had began to boost consciousness concerning the want for unused diabetic provides, and every now and then he would get a donated bundle from somebody providing up insulin, a CGM or different medical tools for individuals who wanted it. 

During the pandemic, issues began to select up. More packages began coming in, and the Embrace Foundation was born.

Now, each Wednesday, Lopez and different volunteers go to a dimly-lit storage facility in Chandler to prepare, label and distribute donated diabetic provides. On the wall behind them, Lopez has taped dozens of letters from donors. Scrawled on pocket book paper in Sharpie or fastidiously printed and typed, many thank him for his work and provide up catalogs of provides together with insulin pens, sterile syringe needles, drugs and — sometimes, however much less continuously — steady glucose displays.

The Embrace Foundation’s web site describes CGM provides as “limited,” and Lopez says that he has to make tough selections about find out how to allocate provides. 

That, he believes, isn’t due to a producing problem or a scarcity of units however just because CGMs are so costly, and so coveted, that sufferers hardly ever have cause to donate them. He says the Embrace Foundation actually solely receives CGM donations from the households of deceased sufferers who don’t want them anymore, if there’s an improve to the technology and a affected person will get entry to a more recent mannequin or if the affected person switches CGM manufacturers.

Dexcom confirmed that the company isn’t experiencing a tool scarcity.

“Dexcom’s product supply isn’t impacting access to CGM, as Dexcom does not have supply challenges at this time,” mentioned James McIntosh, a spokesperson for Dexcom, in an electronic mail. “It’s the need to continue to expand coverage that limits access for some individuals.”

Lopez tries to not discriminate between Type 1 and Type 2 candidates when distributing CGMs, and usually goals for a first-come, first-served strategy, however with not sufficient units to go round, he additionally tries to prioritize emergency conditions. 

That usually means youngsters with Type 1 who aren’t sufficiently old to observe their very own blood glucose ranges, or folks whose diabetes would possibly put them at highest threat of being hospitalized.

“It’s hard to say who deserves them and who doesn’t,” Lopez mentioned. “We always tell people that we’ll be able to give them (a CGM) eventually, but we can’t really determine when that eventually is.”

As of this summer time, there have been 16 folks in Arizona on the Embrace Foundation’s ready checklist for CGMs. Six of these 16 have gotten them thus far.

Another hurdle is that CGMs nonetheless require a prescription, so for individuals who don’t have entry to a health care provider who can prescribe one, the technology is unattainable. Lopez mentioned that his group tells these people find out how to get a prescription, however the majority don’t come again with one. The CGMs stay out of attain. 

Lopez mentioned it may be tough to be the one that has to make robust selections about the place their CGM provides find yourself.

“(Applicants) give me what they give me. They just tell me a little blurb (on the online form), if anything, and it can be hard to kind of just grant who gets this,” he mentioned. “But I try, to my best ability, to decide who would need one, who would benefit from one.”

As Lopez strategizes over scant provides, firms are pondering on a a lot larger scale. In a quarterly earnings name, Insulet, an organization whose technology features a blood glucose monitor built-in with an automatic insulin pump, reported surpassing a billion {dollars} of annual income in 2021. The company mentioned it hopes to develop direct-to-consumer promoting efforts aimed toward folks with each Type 1 and Type 2 diabetes.

Jereme Sylvain, chief monetary officer of Dexcom, described a affected person help program the company launched through the pandemic and has continued to function for people who’ve lost jobs or in any other case qualify for support. But he acknowledged the problem of eliminating the prior authorizations that make it so tough for suppliers to prescribe CGMs.

Dexcom hopes to work with insurance coverage firms — and with the state of Arizona, which is without doubt one of the few states whose Medicaid program doesn’t cover Dexcom — to attempt to enhance entry.

“We really want to put as many folks as possible close to a sensor to better understand what’s going on with their glucose, certainly those impacted by diabetes,” Sylvain mentioned. 

He mentioned the company has to scale up operations to convey down the price of the units. While he emphasised the company’s position in diabetes care, he acknowledged the potential for utilizing CGMs past diabetes.

“We believe that there’s absolutely a space for folks to move beyond (using CGMs just for diabetes),” he mentioned. “There are utilizations that can take place there. But in the end, this is something we really have to work with the FDA to get approval on.”

Lindsy Delco, a spokesperson for Abbott, mentioned in an electronic mail that Abbott doesn’t condone off-label use of their CGMs.

“Our sensing technology has potential for people without diabetes, which is why we’re developing a separate line of consumer biowearables,” she added in the identical electronic mail. “We introduced the world’s first glucose biosensor for athletes last year in Europe, and plan to bring more biowearables under the Lingo brand name in the future.”

Abbott and Dexcom each say they’re prioritizing affordability for diabetics within the meantime, together with applications and company objectives supposed to enhance entry.

Leo, Ernesto, and Summer Huerta display a Dexcom CGM, continuous glucose monitor.
Leo, Ernesto, and Summer Huerta show a Dexcom CGM, steady glucose monitor.
Rob Schumacher/The Republic

But in Avondale, Ernesto Huerta says these adjustments haven’t been reaching folks like him, his spouse, Summer, and his son, Leo. Summer and Leo acquired their diabetes diagnoses inside weeks of one another, and it took them years to find out about CGMs, begin utilizing them, and to navigate insurance coverage adjustments associated to Ernesto’s job.

Sometimes, these adjustments meant they could not afford the CGMs for weeks at a time. And they nonetheless expertise sure weeks the place Summer and Leo cannot each put on the units that might save their lives, for monetary causes.

“Some of these companies … they do have some programs that will help you. (But) you have to jump through hoops and I don’t see how anybody, anybody under any poverty level can run through those hoops,” Ernesto mentioned.

The silver lining, Ernesto mentioned, was not the large firms, however fairly the folks on the bottom who had been keen to assist, a community of diabetics and their households who stockpiled provides and gave them to others when conditions turned determined. 

He described the father or mother of considered one of his son’s mates who gave them a vial of insulin after they actually wanted it, or one other father or mother who gave them some further provides as a result of the actual model wasn’t working for his or her household.

That, he says, is the place he discovered solace whereas he appeared for CGMs — not within the system that already existed.

“I felt deserted. Like the whole system just deserted my family,” Ernesto mentioned. “They needed the help, but it’s not affordable enough for me to actually help my family.”

Independent protection of bioscience in Arizona is supported by a grant from the Flinn Foundation.

Melina Walling is a bioscience reporter who covers COVID-19, health, technology, agriculture and the surroundings. You can contact her by way of electronic mail at [email protected], or on Twitter @MelinaWalling.

Back to top button